Skip to Content

APO RIS 150 (Risedronate sodium 150 mg)

Pill imprint APO RIS 150 has been identified as Risedronate sodium 150 mg.

Risedronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Risedronate sodium 150 mg APO RIS 150
Risedronate sodium 150 mg APO RIS 150
Discount Card Promo
Risedronate sodium
Imprint:
APO RIS 150
Strength:
150 mg
Color:
Blue
Shape:
Round
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide